Basic Information
ID: ALA651378
Type: Functional
Description: Optimal dose required to inhibit human renal Caki 2 tumor growth after subcutaneous transplantation on athymic mice at 10 mg/kg (treatment schedule: q4dX3)
Organism: Homo sapiens
Cell type: CAKI-2
Activity Charts
Bioactivity
Activity Types for Assay ALA651378
Optimal dose
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 760.05 | 1.86 | 1.86 |